TUESDAY, April 3, 2018 (American Heart Association) -- Heart stent patients with a certain gene mutation may need to consider alternatives to Plavix, a commonly prescribed blood thinner, a new study suggests.
Researchers reported Tuesday that mutation-carrying patients are much less likely to have or die from a heart attack, stroke or other major complication within a year if they take a substitute blood thinner.
FRIDAY, April 6, 2018 -- Having a chronic heart condition is stressful enough, but new research suggests the cost of caring for the condition is also a huge financial burden for poorer families in the United States.
One in four low-income families carry a significant financial load from out-of-pocket expenses for chronic heart disease treatment. For one in 10 low-income families -- including those who have insurance -- those expenses trigger a catastrophic financial crisis, the study found.
FRIDAY, Feb. 23, 2018 -- The antibiotic clarithromycin (brand name: Biaxin) may increase the long-term risk of heart problems and death in patients with heart disease, according to U.S. health officials.
As a result, the federal Food and Drug Administration said Thursday that it's recommending that doctors carefully weigh the benefits and risks of the drug before prescribing it to patients with heart problems.